An Outline of BNCT and Switchover to Accelerator Based BNCT System
openaire +2 more sources
LAT1 expression in head and neck cancer: a prognostic biomarker with potential relevance for BNCT. [PDF]
Cavalieri S +7 more
europepmc +1 more source
Boron Neutron Capture Therapy as a Novel Approach for Chondrosarcoma: Case Study of Tumor Reduction and Long-term Control. [PDF]
Hong J +17 more
europepmc +1 more source
Boron neutron capture therapy in the context of tumor heterogeneity: progress, challenges, and future perspectives. [PDF]
Zhou R, You Z, Liu L.
europepmc +1 more source
Boron Neutron Capture Therapy in Recurrent High-Grade Gliomas: Safety, Efficacy, and Pharmacokinetics From a Multicenter, Dose-Escalation Phase 1 Trial. [PDF]
Kim W +14 more
europepmc +1 more source
Hypo-segmentation of <sup>18</sup>F-BPA PET-based boron distribution: a pragmatic approach for efficient BNCT treatment planning. [PDF]
Teng YC +4 more
europepmc +1 more source
A LAT1-selective PET tracer, 5-[¹⁸F]F-αMe-3BPA, as a companion to its structurally matched ¹⁰B analog in boron neutron capture therapy. [PDF]
Kondo N +5 more
europepmc +1 more source
Research on the dose calculation of BNCT based on the time-varying boron concentration in pharmacokinetics. [PDF]
Chen Y +10 more
europepmc +1 more source
L‑type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review). [PDF]
Zheng X, Pan J, Lin D, Shao W.
europepmc +1 more source
Predictive factors of oral mucositis in patients with locally recurrent inoperable head and neck cancer treated with boron neutron capture therapy. [PDF]
Mälkiä T +7 more
europepmc +1 more source

